Prokidney (PROK) Net Shares Issued and Repurchased (2022 - 2026)
Prokidney's (PROK) quarterly Net Shares Issued and Repurchased came in at $10.9 million in Q1 2026, little changed year-over-year from $10.9 million in Q1 2025, and down 19.82% quarter-over-quarter from $13.6 million in Q4 2025.
Analysis
Prokidney (PROK) Net Shares Issued and Repurchased (2022 - 2026) Analysis & Trends
Prokidney (PROK) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $10.9 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased changed 0.15% year-over-year to $10.9 million in Q1 2026; TTM through Mar 2026 was $10.9 million, a 0.15% change from a year earlier, with the FY2025 full-year figure at $13.6 million, up 52.9% from the prior year.
- Net Shares Issued and Repurchased was $10.9 million for Q1 2026 at Prokidney, down from $13.6 million in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $13.6 million in Q4 2025 and troughed at $3.6 million in Q4 2022.
- A 5-year average of $10.1 million and a median of $10.9 million in 2025 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased soared 243.09% in 2023 and retreated 28.96% in 2024, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $3.6 million in 2022, then soared by 243.09% to $12.5 million in 2023, then dropped by 28.96% to $8.9 million in 2024, then soared by 52.9% to $13.6 million in 2025, then slipped by 19.82% to $10.9 million in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $10.9 million (Q1 2026), $13.6 million (Q4 2025), and $10.9 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 10.88 Mn |
| Dec 31, 2025 | 13.56 Mn |
| Mar 31, 2025 | 10.89 Mn |
| Dec 31, 2024 | 8.87 Mn |
| Dec 31, 2023 | 12.49 Mn |
| Dec 31, 2022 | 3.64 Mn |